Chargement en cours...

Misclassification in assessment of diabetogenic risk using electronic health records()

PURPOSE: Suspected diabetogenic effects or drug indication may increase testing for diabetes mellitus (DM), resulting in measurement bias when evaluating diabetogenic drug effects. We sought to evaluate the validity of electronic health record data in determining DM risk. METHODS: We used time-depen...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharmacoepidemiol Drug Saf
Auteurs principaux: Winterstein, Almut G., Kubilis, Paul, Bird, Steve, Cooper-DeHoff, Rhonda M., Nichols, Greg A., Delaney, Joseph A.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5012172/
https://ncbi.nlm.nih.gov/pubmed/24923707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3656
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!